The Implied Analyst 12-Month Target For PXSG

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the PowerShares Russell 2000 Pure Growth Portfolio ETF ( PXSG), we found that the implied analyst target price for the ETF based upon its underlying holdings is $30.13 per unit.

START SLIDESHOW:
10 ETFs With Most Upside To Analyst Targets »

With PXSG trading at a recent price near $25.86 per unit, that means that analysts see 16.53% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of PXSG's underlying holdings with notable upside to their analyst target prices are AcelRx Pharmaceuticals Inc ( ACRX), Achillion Pharmaceuticals Inc. ( ACHN), and Inovio Pharmaceuticals Inc. ( INO). Although ACRX has traded at a recent price of $3.15/share, the average analyst target is 161.90% higher at $8.25/share. Similarly, ACHN has 116.81% upside from the recent share price of $4.74 if the average analyst target price of $10.28/share is reached, and analysts on average are expecting INO to reach a target price of $13.75/share, which is 65.07% above the recent price of $8.33. Below is a twelve month price history chart comparing the stock performance of ACRX, ACHN, and INO:

ACRX, ACHN, and INO Relative Performance Chart

Below is a summary table of the current analyst target prices discussed above:

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target
PowerShares Russell 2000 Pure Growth Portfolio ETF PXSG $25.86 $30.13 16.53%
AcelRx Pharmaceuticals Inc ACRX $3.15 $8.25 161.90%
Achillion Pharmaceuticals Inc. ACHN $4.74 $10.28 116.81%
Inovio Pharmaceuticals Inc. INO $8.33 $13.75 65.07%

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

The average analyst target price data upon which this article was based, is courtesy of data provided by Zacks Investment Research via Quandl.com.
Get the latest Zacks research report on ACRX — FREE
Get the latest Zacks research report on ACHN — FREE
Get the latest Zacks research report on INO — FREE

If you liked this article you might like

Notable Two Hundred Day Moving Average Cross - PXSG

Notable Two Hundred Day Moving Average Cross - PXSG